ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

The Role of FLT3 Inhibitors in Acute Myeloid Leukemia

Raoul Tibes, MD, PhD
Published Online:1:34 PM, Wed July 27, 2016


Raoul Tibes, MD, PhD, physician-scientist at the University Hospital Head Myeloid Malignancies, Department of Internal Medicine II at the University Hospital in W├╝rzburg, and adjunct consultant at Mayo Clinic, discusses the role of FLT3 inhibitors in the treatment of patients with acute myeloid leukemia.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.